Trump administration authorises 172 million barrel SPR drawdown as 32 IEA nations coordinate record emergency oil release
Read More 5 minute read Pharma Industry News Why Leo Pharma’s completed Spevigo deal with Boehringer could reshape rare skin disease care Leo Pharma completes its acquisition of Spevigo® from Boehringer Ingelheim. Learn how this rare disease drug strengthens its dermatology growth strategy. byPallavi MadhirajuOctober 1, 2025